Allergan News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

16.11.17	Allergan to Present at the Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference (PR Newswire)
14.11.17	Overactive Bladder Causes Significant Burden, Regardless of Age Amongst Adults (PR Newswire)
14.11.17	FDA Nod For AGN, ZYME Strikes A Deal With Janssen Biotech, TCON Abuzz (RTTNews)
13.11.17	Allergan Receives FDA Approval For Label Expansion Of VRAYLAR - Quick Facts (RTTNews)
13.11.17	Allergan Receives FDA Approval For Use of VRAYLAR™ (cariprazine) in the Maintenance Treatment of Schizophrenia (PR Newswire)
10.11.17	Amgen, Allergan Get Positive CHMP Opinion For ABP 215, Biosimilar Bevacizumab (RTTNews)
10.11.17	Amgen And Allergan Receive Positive CHMP Opinion For ABP 215 (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer (PR Newswire)
08.11.17	SS&C Releases Second Round of 2017 Product Upgrades (PR Newswire)
08.11.17	Allergan to Present Dynamic Eye Care Data at American Academy of Ophthalmology Meeting in New Orleans (PR Newswire)
07.11.17	Allergan to Present at Credit Suisse 26th Annual Healthcare Conference (PR Newswire)
06.11.17	L'Office des normes techniques et de la sécurité présente sa maison de protection contre le monoxyde de carbone et utilise la réalité augmentée pour éduquer le public (PR Newswire)
01.11.17	MÄRKTE USA/Dow & Co lassen sich auf Rekordjagd von Fed nicht beirren (Dow Jones)
01.11.17	ASH 2017: Janssen to Present 40 Abstracts, Including 8 Oral Presentations, with New Data on DARZALEX® (daratumumab), IMBRUVICA® (ibrutinib) and Other Compounds from Robust Portfolio (PR Newswire)
01.11.17	MÄRKTE USA/Wall Street wieder auf Rekordkurs (Dow Jones)
01.11.17	IKEA Canada prolonge son partenariat avec le Club des petits déjeuners pour soutenir le développement des jeunes enfants dans des collectivités d'un océan à l'autre. (PR Newswire)
01.11.17	Allergan Inc. Q3 Income Advances 7% (RTTNews)
01.11.17	Allergan Reports Solid Top-Line Execution in Third Quarter 2017 with 11% Increase in GAAP Net Revenues to $4.03 Billion (PR Newswire)
01.11.17	Aegon Completes Sale of Unirobe Meeùs Groep (PR Newswire)
01.11.17	Aegon Completes Sale of Unirobe Meeùs Groep (PR Newswire)
31.10.17	Allergan Presented New Phase 3 Data of Ulipristal Acetate in Women with Uterine Fibroids at the American Society for Reproductive Medicine Annual Congress (PR Newswire)
30.10.17	Allergan Gets China Approval For Ozurdex To Treat Retinal Vein Occlusion (RTTNews)
30.10.17	Allergan Receives Approval for Ozurdex® (Dexamethasone Intravitreal Implant 0.7 mg) in China for the Treatment of Retinal Vein Occlusion (RVO) (PR Newswire)
27.10.17	Allergan Board of Directors Announces Fourth Quarter 2017 Cash Dividend and Increases Quarterly Cash Dividend for 2018 (PR Newswire)
26.10.17	CoolSculpting® Breaks the Ice about Non-Invasive Fat Freezing with Actress Debra Messing (PR Newswire)
20.10.17	Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a) (PR Newswire)
19.10.17	Allergan Issues Investor FAQ on Federal District Court RESTASIS® Patent Decision (PR Newswire)
16.10.17	Allergan to Present New Data at the World Congress of Gastroenterology at ACG 2017 (PR Newswire)
13.10.17	Allergan Reports Settlement On RESTASIS 0.05% Patent Litigation With InnoPharma (RTTNews)
11.10.17	Allergan to Present Data From More Than 20 Abstracts at the 2017 Fall Clinical Dermatology Conference (PR Newswire)
11.10.17	CRY Opens Wallet, LLY's JUNIPER Flops, MDXG Catches Eyes, RNN Awaits DATA In Q4 (RTTNews)
10.10.17	Allergan: FDA Accepts NDA For Ulipristal Acetate For Uterine Fibroids (RTTNews)
09.10.17	Allergan to Present New Dry Eye Data at the American Academy of Optometry Meeting in Chicago (PR Newswire)
05.10.17	Allergan Presents Data From Seventeen Abstracts At The 2017 American Society For Dermatologic Surgery Meeting In Chicago (PR Newswire)
04.10.17	Allergan To Present New Data From Its Anti-Infectives Portfolio At IDWeek 2017 In San Diego (PR Newswire)
03.10.17	FDA Approves BOTOX® Cosmetic (OnabotulinumtoxinA) for the Temporary Improvement in the Appearance of Moderate to Severe Forehead Lines Associated with Frontalis Muscle Activity In Adults (PR Newswire)
03.10.17	VICL Soars After-hours, DMTX Deems RARE Bid Superior, MDXG On Watch (RTTNews)
02.10.17	La FCSQ souligne la Semaine contre l'intimidation et la violence à l'école (PR Newswire)
02.10.17	Allergan: FDA To Review SNDA For AVYCAZ; Filing Seeks To Expand Label (RTTNews)
02.10.17	FDA Accepts Supplemental New Drug Application (sNDA) filing for AVYCAZ® (ceftazidime and avibactam) (PR Newswire)
02.10.17	Allergan to Report Third Quarter 2017 Earnings and Host Conference Call and Webcast (PR Newswire)
26.09.17	S3 Partners Launches BLACK APP 2.0 on the Bloomberg App Portal (PR Newswire)
26.09.17	ACZONE® (dapsone) Gel, 7.5% Recognized With Teen Vogue Acne Award Win (PR Newswire)
25.09.17	Location Intelligence Goes In-House with Ubimo's Polaris (PR Newswire)
25.09.17	Allergan EVP And CFO Tessa Hilado Decides To Retire - Quick Facts (RTTNews)
25.09.17	Allergan Board Authorizes $2 Bln Share Buyback; Reaffirms 2017 Guidance (RTTNews)
25.09.17	Allergan Announces Tessa Hilado, Executive Vice President and Chief Financial Officer, to Retire from Company (PR Newswire)
25.09.17	Allergan Board of Directors Authorizes New $2 Billion Share Repurchase Program, Affirms Commitment to Increasing Cash Dividend Annually (PR Newswire)
25.09.17	Opdivo, Keytruda Back In The News, FDA Snubs AGN, EARS Catches Eyes (RTTNews)
22.09.17	Allergan Receives Refusal to File Letter from FDA for Vraylar® (cariprazine) Supplemental New Drug Application (sNDA) for the Treatment of Negative Symptoms in Schizophrenia (PR Newswire)
22.09.17	New Data from CENTAUR Phase 2b Clinical Study Supports Continued Development of Cenicriviroc (CVC) in Ongoing Phase 3 AURORA Trial (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Geberit	500.80	1.23 %	K V
Zurich Insur Gr	534.60	0.98 %	K V
Swisscom	511.00	0.69 %	K V
Swiss Re	133.20	0.68 %	K V
Givaudan	3’870.00	0.57 %	K V
Novartis	90.03	-0.09 %	K V
Nestle	73.58	-0.78 %	K V
Part Grp Hldg	1’278.50	-0.97 %	K V
Alcon	74.90	-1.06 %	K V
CieFinRichemont	138.70	-1.07 %	K V

mehr

09.02.20		Ausblick: Allergan veröffentlicht Zahlen zum vergangenen Quartal
04.10.19		Molecular Partners-Aktie gefragt: Molecular Partners kündigt neue Daten vom Partner Allergan zu Augenmittel an
04.08.19		Ausblick: Allergan stellt Ergebnisse des abgelaufenen Quartals vor
05.05.19		Ausblick: Allergan informiert über die jüngsten Quartalsergebnisse
19.02.18		Molecular Partners: Partner Allergan zieht weitere Option für DARPin-Kandidaten
22.12.17		Novartis erreicht Zwischenerfolg in Patentstreit mit Allergan

09.02.20

Ausblick: Allergan veröffentlicht Zahlen zum vergangenen Quartal

04.10.19

Molecular Partners-Aktie gefragt: Molecular Partners kündigt neue Daten vom Partner Allergan zu Augenmittel an

04.08.19

Ausblick: Allergan stellt Ergebnisse des abgelaufenen Quartals vor

05.05.19

Ausblick: Allergan informiert über die jüngsten Quartalsergebnisse

19.02.18

Molecular Partners: Partner Allergan zieht weitere Option für DARPin-Kandidaten

22.12.17

Novartis erreicht Zwischenerfolg in Patentstreit mit Allergan